Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Readability User Testing is Requested in EAEU
Does your company know that User Testing of Patient Information Leaflet (PIL testing/ Readability user testing (RUT)) of medicines is requested in EAEU region according to decision of the Eurasian Economic Commission (EEC) No. 88.?
To conduct PIL testing, you should:
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS and EU markets in the field of regulatory services for pharmaceutical companies.
We are delighted to propose PIL testing in EAEU performed by Inpharmatis - leading provider with great practical experience and expertise of PIL testing in EAEU region.
Inpharmatis has been involved with readability testing since the beginning of the EU requirement in 2005.
Our approval rates are 100% - leaving aside projects where clients have ignored our initial advice regarding leaflet changes.
If you want to conduct PIL testing and find out further information, please contact us email@example.com.
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022